525 related articles for article (PubMed ID: 15624200)
1. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels.
Davis BH; Zarev PV
Cytometry B Clin Cytom; 2005 Jan; 63(1):16-22. PubMed ID: 15624200
[TBL] [Abstract][Full Text] [Related]
2. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
Baeten D; Møller HJ; Delanghe J; Veys EM; Moestrup SK; De Keyser F
Arthritis Rheum; 2004 May; 50(5):1611-23. PubMed ID: 15146432
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis.
Fabriek BO; Møller HJ; Vloet RP; van Winsen LM; Hanemaaijer R; Teunissen CE; Uitdehaag BM; van den Berg TK; Dijkstra CD
J Neuroimmunol; 2007 Jul; 187(1-2):179-86. PubMed ID: 17537523
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of monocyte CD163 in single- and dual-asthmatic responders during allergen-induced bronchoconstriction.
Kowal K; Møller HJ; Dubuske LM; Moestrup SK; Bodzenta-Lukaszyk A
Clin Exp Allergy; 2006 Dec; 36(12):1584-91. PubMed ID: 17177682
[TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface CD163 expression.
Maniecki MB; Etzerodt A; Moestrup SK; Møller HJ; Graversen JH
Immunobiology; 2011 Aug; 216(8):882-90. PubMed ID: 21458881
[TBL] [Abstract][Full Text] [Related]
6. Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease.
Møller HJ; de Fost M; Aerts H; Hollak C; Moestrup SK
Eur J Haematol; 2004 Feb; 72(2):135-9. PubMed ID: 14962251
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
[TBL] [Abstract][Full Text] [Related]
8. Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio.
Moreno JA; Dejouvencel T; Labreuche J; Smadja DM; Dussiot M; Martin-Ventura JL; Egido J; Gaussem P; Emmerich J; Michel JB; Blanco-Colio LM; Meilhac O
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1253-62. PubMed ID: 20299688
[TBL] [Abstract][Full Text] [Related]
9. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
Lapuc I; Bolkun L; Eljaszewicz A; Rusak M; Luksza E; Singh P; Miklasz P; Piszcz J; Ptaszynska-Kopczynska K; Jasiewicz M; Kaminski K; Dabrowska M; Bodzenta-Lukaszyk A; Kloczko J; Moniuszko M
Oncol Rep; 2015 Sep; 34(3):1269-78. PubMed ID: 26135617
[TBL] [Abstract][Full Text] [Related]
10. Expression of soluble sCD163 in serum of psoriatic patients is modulated by Goeckerman therapy.
Kondelkova K; Krejsek J; Borska L; Fiala Z; Hamakova K; Andrys C
Allergol Immunopathol (Madr); 2013; 41(3):158-62. PubMed ID: 22765877
[TBL] [Abstract][Full Text] [Related]
11. Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding.
Møller HJ; Nielsen MJ; Maniecki MB; Madsen M; Moestrup SK
Immunobiology; 2010 May; 215(5):406-12. PubMed ID: 19581020
[TBL] [Abstract][Full Text] [Related]
12. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
[TBL] [Abstract][Full Text] [Related]
13. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
Andersen MN; Abildgaard N; Maniecki MB; Møller HJ; Andersen NF
Eur J Haematol; 2014 Jul; 93(1):41-7. PubMed ID: 24612259
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure.
Hiraoka A; Horiike N; Akbar SM; Michitaka K; Matsuyama T; Onji M
J Gastroenterol; 2005 Jan; 40(1):52-6. PubMed ID: 15692789
[TBL] [Abstract][Full Text] [Related]
16. Serum soluble CD163 levels in patients with influenza-associated encephalopathy.
Hasegawa S; Matsushige T; Inoue H; Takahara M; Kajimoto M; Momonaka H; Ishida C; Tanaka S; Morishima T; Ichiyama T
Brain Dev; 2013 Aug; 35(7):626-9. PubMed ID: 23149357
[TBL] [Abstract][Full Text] [Related]
17. Serum soluble CD163 and interleukin-6 levels in women with ovarian endometriomas.
Jee BC; Suh CS; Kim SH; Moon SY
Gynecol Obstet Invest; 2008; 66(1):47-52. PubMed ID: 18311079
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD163.
Møller HJ
Scand J Clin Lab Invest; 2012 Feb; 72(1):1-13. PubMed ID: 22060747
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitro.
Bauer S; Weiss TS; Wiest R; Schacherer D; Hellerbrand C; Farkas S; Scherer MN; Ritter M; Schmitz G; Schäffler A; Buechler C
Exp Mol Pathol; 2011 Dec; 91(3):733-9. PubMed ID: 21839737
[TBL] [Abstract][Full Text] [Related]
20. Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome.
Schaer DJ; Schleiffenbaum B; Kurrer M; Imhof A; Bächli E; Fehr J; Moller HJ; Moestrup SK; Schaffner A
Eur J Haematol; 2005 Jan; 74(1):6-10. PubMed ID: 15613100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
